First Time Loading...

Cerevel Therapeutics Holdings Inc
NASDAQ:CERE

Watchlist Manager
Cerevel Therapeutics Holdings Inc Logo
Cerevel Therapeutics Holdings Inc
NASDAQ:CERE
Watchlist
Price: 40.27 USD 0.62% Market Closed
Updated: Jun 11, 2024

Cerevel Therapeutics Holdings Inc
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cerevel Therapeutics Holdings Inc
Net Issuance of Common Stock Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Cerevel Therapeutics Holdings Inc
NASDAQ:CERE
Net Issuance of Common Stock
$517.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Issuance of Common Stock
-$1.1B
CAGR 3-Years
-9%
CAGR 5-Years
37%
CAGR 10-Years
-18%
Gilead Sciences Inc
NASDAQ:GILD
Net Issuance of Common Stock
-$719m
CAGR 3-Years
-22%
CAGR 5-Years
22%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Issuance of Common Stock
-$288.7m
CAGR 3-Years
15%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Issuance of Common Stock
-$473.2m
CAGR 3-Years
51%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Cerevel Therapeutics Holdings Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
517.5m USD

Based on the financial report for Dec 31, 2023, Cerevel Therapeutics Holdings Inc's Net Issuance of Common Stock amounts to 517.5m USD.

What is Cerevel Therapeutics Holdings Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 1Y
106%

Over the last year, the Net Issuance of Common Stock growth was 106%.